Myriad Genetics partners with SOPHiA GENETICS on liquid biopsy test
Go back to Myriad Genetics partners with SOPHiA GENETICS on liquid biopsy test| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 5.32 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.32 | 52 Week High | $45.34 | |||
| Open | $5.32 | 52 Week Low | $15.92 | |||
| Day High | $5.32 | P/E | 2.28 | |||
| Day Low | $5.32 | EPS | $2.33 | |||
| Volume | 10 | |||||
| (NASDAQ: SOPH) | Delayed: 5.57 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.57 | 52 Week High | $ | |||
| Open | $5.57 | 52 Week Low | $ | |||
| Day High | $5.57 | P/E | N/A | |||
| Day Low | $5.57 | EPS | $ | |||
| Volume | 3 | |||||

